Skip to main content
SpringerLink
Log in

Cannabidiol- and tetrahydrocannabinol-related AEs

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Stack SK, et al. The Effectiveness and Adverse Events of Cannabidiol and Tetrahydrocannabinol Used in the Treatment of Anxiety Disorders in a PTSD Subpopulation: An Interim Analysis of an Observational Study Journal of Pharmacy Technology 39 : 172-182, No. 4, Aug 2023. Available from: URL: http://doi.org/10.1177/87551225231180796

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cannabidiol- and tetrahydrocannabinol-related AEs. Reactions Weekly 1969, 8 (2023). https://doi.org/10.1007/s40278-023-44474-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-44474-8

Search

Navigation